Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Tufts Medical Center
mi
from
Boston, MA
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Sparrow Health System - Sparrow Hospital
mi
from
Lansing, MI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Sparrow Health System - Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Northern Michigan Hospital
mi
from
Petoskey, MI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Northern Michigan Hospital
mi
from
Petoskey, MI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Lakeland Hospitals at St. Joseph
mi
from
St. Joseph, MI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Lakeland Hospitals at St. Joseph
mi
from
St. Joseph, MI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Memorial Hospital at Gulfport
mi
from
Gulfport, MS
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Memorial Hospital at Gulfport
mi
from
Gulfport, MS
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Freeman West Hospital
mi
from
Joplin, MO
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Freeman West Hospital
mi
from
Joplin, MO
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Our Lady of Lourdes Medical Center
mi
from
Haddon Heights, NJ
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Our Lady of Lourdes Medical Center
mi
from
Haddon Heights, NJ
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Jersey Shore University Medical Center
mi
from
Sea Girt, NJ
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Jersey Shore University Medical Center
mi
from
Sea Girt, NJ
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
St. Joseph's Hospital Health Center
mi
from
Liverpool, NY
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
St. Joseph's Hospital Health Center
mi
from
Liverpool, NY
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
St. Elizabeth Medical Center
mi
from
Utica, NY
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
St. Elizabeth Medical Center
mi
from
Utica, NY
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Wake Medical Center
mi
from
Raleigh, NC
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Wake Medical Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Ohio State University Medical Center
mi
from
Columbus, OH
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
St. Mary Medical Center
mi
from
Yardley, PA
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
St. Mary Medical Center
mi
from
Yardley, PA
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Sisters of Charity Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Grand Strand Regional Medical Center
mi
from
Myrtle Beach, SC
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Grand Strand Regional Medical Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Regional Hospital
mi
from
Jackson, TN
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Regional Hospital
mi
from
Jackson, TN
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Centennial Medical Center
mi
from
Nashville, TN
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
CRSTI/Medical City Dallas
mi
from
Dallas, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
CRSTI/Medical City Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Kingwood Medical Center Hospital
mi
from
Kingwood, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Kingwood Medical Center Hospital
mi
from
Kingwood, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Methodist Texsan Hospital
mi
from
San Antonio, TX
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Methodist Texsan Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
Meriter Hospital, Inc.
mi
from
Madison, WI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
Meriter Hospital, Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated:  1/6/2016
CaRE Foundation, Inc
mi
from
Wausau, WI
ION US Post-Approval Study
A U.S. Post-Approval Study of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Status: Enrolling
Updated: 1/6/2016
CaRE Foundation, Inc
mi
from
Wausau, WI
Click here to add this to my saved trials
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Status: Enrolling
Updated:  1/7/2016
The Mayo Clinic
mi
from
Rochester, MN
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III
Status: Enrolling
Updated: 1/7/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Mobile Heart Specialists, PC
mi
from
Mobile, AL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Mobile Heart Specialists, PC
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Silicon Valley Medical Imaging
mi
from
Fremont, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Silicon Valley Medical Imaging
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
VA Greater Los Angeles Healthcare System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Westside Medical Associates of Los Angeles
mi
from
Los Angeles, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Westside Medical Associates of Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Ventura Clinical Trials
mi
from
Malibu, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Ventura Clinical Trials
mi
from
Malibu, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Mission Internal Medical Group
mi
from
Mission Viejo, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Mission Internal Medical Group
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
VA San Diego Healthcare System
mi
from
San Diego, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Santa Rosa Cardiology Medical Group, Inc.
mi
from
Santa Rosa, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Santa Rosa Cardiology Medical Group, Inc.
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
HOCC - New Britain Campus
mi
from
New Britain, CT
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
HOCC - New Britain Campus
mi
from
New Britain, CT
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Yale University
mi
from
New Haven, CT
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Alfieri Cardiology
mi
from
Newark, DE
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Alfieri Cardiology
mi
from
Newark, DE
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Delaware Clinical Trials
mi
from
Wilmington, DE
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Delaware Clinical Trials
mi
from
Wilmington, DE
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Elite Research and Clinical Trials
mi
from
Aventura, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Elite Research and Clinical Trials
mi
from
Aventura, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
S&W Clinical Research
mi
from
Fort Lauderdale, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
S&W Clinical Research
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Florida Heart Associates
mi
from
Fort Myers, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Florida Heart Associates
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
St. Luke's Cardiology St. Vincent's HealthCare
mi
from
Jacksonville, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
St. Luke's Cardiology St. Vincent's HealthCare
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
East Coast Institute for Research
mi
from
Jacksonville, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
East Coast Institute for Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
Watson Medical Clinic/Lakeland Regional Medical Clinic
mi
from
Lakeland, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
Watson Medical Clinic/Lakeland Regional Medical Clinic
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated:  1/7/2016
MIMA Century Research Associates
mi
from
Melbourne, FL
A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
A Phase 3b, Open-Label, Parallel Group, Randomized, Multicenter Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)
Status: Enrolling
Updated: 1/7/2016
MIMA Century Research Associates
mi
from
Melbourne, FL
Click here to add this to my saved trials